[The protective effects of vitamin E on lung injury caused by high temperature and PM2.5 in COPD rats]

Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2019 Jul 28;35(4):293-296. doi: 10.12047/j.cjap.5788.2019.061.
[Article in Chinese]

Abstract

Objective: To investigate the effects of vitamin E on the respiratory function impairment in rats with chronic obstructive pulmonary disease (COPD) after exposed to high temperature and PM2.5.

Methods: Fifty-four 7-week-old SPF male Wistar rats were randomly divided into 9 experimental groups (n=6). The rat COPD model was established by lipopolysaccharide (LPS) and smoke exposure. After modeled, the rats were tracheal instilled with PM2.5 (0 mg/ml, 3.2 mg/ml) and intraperitoneally injected with vitamin E at the dose of 40 mg/kg (20 mg/ml). Part of rats (high temperature groups) were then exposed to high temperature (40℃), once (8 h) a day for three consecutive days. After the last exposure, the lung function of rats was detected. The expression levels of inducible nitric oxide synthase (iNOS), tumor necrosis factor-α (TNF-α) and monocyte chemotactic protein-1 (MCP-1) were detected by corresponding ELISA kits.

Results: Compared with the control group, exposure of high temperature and PM2.5 could inhibit the lung function of COPD rats significantly (P<0.05); the level of MCP-1 was increased significantly in PM2.5-exposure groups (P<0.05); iNOS was increased significantly in the groups of high temperature (P<0.05). Compared with the single-PM2.5 exposure groups, TNF-α in lung was decreased in the normal temperature health group and high temperature COPD group (P<0.05) after treated with vitamin E; MCP-1 was decreased in all vitamin E-treated groups (P<0.05); the decreased iNOS only appeared in the group of high temperature with vitamin E treatment.

Conclusion: High temperature and PM2.5 could aggravate the inflammation of COPD rats. As an antioxidant, vitamin E may protect the lung from the damage effects.

MeSH terms

  • Animals
  • Chemokine CCL2 / metabolism
  • Hot Temperature / adverse effects*
  • Lung / physiopathology
  • Male
  • Nitric Oxide Synthase Type II / metabolism
  • Particulate Matter / adverse effects*
  • Pulmonary Disease, Chronic Obstructive / drug therapy*
  • Random Allocation
  • Rats
  • Rats, Wistar
  • Tumor Necrosis Factor-alpha / metabolism
  • Vitamin E / pharmacology*

Substances

  • Ccl2 protein, rat
  • Chemokine CCL2
  • Particulate Matter
  • Tumor Necrosis Factor-alpha
  • Vitamin E
  • Nitric Oxide Synthase Type II
  • Nos2 protein, rat